These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

659 related items for PubMed ID: 15159268

  • 1. Bone mineral density thresholds for pharmacological intervention to prevent fractures.
    Siris ES, Chen YT, Abbott TA, Barrett-Connor E, Miller PD, Wehren LE, Berger ML.
    Arch Intern Med; 2004 May 24; 164(10):1108-12. PubMed ID: 15159268
    [Abstract] [Full Text] [Related]

  • 2. European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
    Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY, Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF).
    Osteoporos Int; 2013 Jan 24; 24(1):23-57. PubMed ID: 23079689
    [Abstract] [Full Text] [Related]

  • 3. Application of Osteorisk to postmenopausal patients with osteoporosis.
    Steiner ML, Fernandes CE, Strufaldi R, Porto EC, Pompei Lde M, Peixoto S.
    Sao Paulo Med J; 2010 Jan 24; 128(1):24-9. PubMed ID: 20512277
    [Abstract] [Full Text] [Related]

  • 4. European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
    Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster JY, Borgstrom F, Rizzoli R, European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
    Osteoporos Int; 2008 Apr 24; 19(4):399-428. PubMed ID: 18266020
    [Abstract] [Full Text] [Related]

  • 5. Evaluation and management of osteoporosis following hospitalization for low-impact fracture.
    Simonelli C, Chen YT, Morancey J, Lewis AF, Abbott TA.
    J Gen Intern Med; 2003 Jan 24; 18(1):17-22. PubMed ID: 12534759
    [Abstract] [Full Text] [Related]

  • 6. [Indication of bone densitometry in women over 40 years of age].
    Moreno Girao M, Centelles Mañosa F, Jovell Fernández E.
    Aten Primaria; 2005 Mar 31; 35(5):253-7. PubMed ID: 15802113
    [Abstract] [Full Text] [Related]

  • 7. Osteoporosis: Its Prosthodontic Considerations - A Review.
    Bandela V, Munagapati B, Karnati RK, Venkata GR, Nidudhur SR.
    J Clin Diagn Res; 2015 Dec 31; 9(12):ZE01-4. PubMed ID: 26816999
    [Abstract] [Full Text] [Related]

  • 8. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial.
    Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA, Palermo L, Prineas R, Rubin SM, Scott JC, Vogt T, Wallace R, Yates AJ, LaCroix AZ.
    JAMA; 2015 Dec 31; 280(24):2077-82. PubMed ID: 9875874
    [Abstract] [Full Text] [Related]

  • 9. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.
    Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A.
    J Bone Miner Res; 2007 Mar 31; 22(3):465-75. PubMed ID: 17144789
    [Abstract] [Full Text] [Related]

  • 10. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures.
    Johnell O, Kanis JA.
    Osteoporos Int; 2006 Dec 31; 17(12):1726-33. PubMed ID: 16983459
    [Abstract] [Full Text] [Related]

  • 11. Dual-energy X-ray absorptiometry body composition in patients with secondary osteoporosis.
    Messina C, Monaco CG, Ulivieri FM, Sardanelli F, Sconfienza LM.
    Eur J Radiol; 2016 Aug 31; 85(8):1493-8. PubMed ID: 27048946
    [Abstract] [Full Text] [Related]

  • 12. Treatments for post-menopausal osteoporotic women, what's new? How can we manage long-term treatment?
    Herrero S, Pico Y.
    Eur J Pharmacol; 2016 May 15; 779():8-21. PubMed ID: 26923729
    [Abstract] [Full Text] [Related]

  • 13. Effect of Sodium Fluoride on Bone Biomechanical and Histomorphometric Parameters and on Insulin Signaling and Insulin Sensitivity in Ovariectomized Rats.
    de Cássia Alves Nunes R, Chiba FY, Pereira AG, Pereira RF, de Lima Coutinho Mattera MS, Ervolino E, Louzada MJ, Buzalaf MA, Silva CA, Sumida DH.
    Biol Trace Elem Res; 2016 Sep 15; 173(1):144-53. PubMed ID: 26876375
    [Abstract] [Full Text] [Related]

  • 14. Bisphosphonate Treatment in Osteoporosis: Optimal Duration of Therapy and the Incorporation of a Drug Holiday.
    Villa JC, Gianakos A, Lane JM.
    HSS J; 2016 Feb 15; 12(1):66-73. PubMed ID: 26855630
    [Abstract] [Full Text] [Related]

  • 15. Alterations in collagen and mineral nanostructure observed in osteoporosis and pharmaceutical treatments using simultaneous small- and wide-angle X-ray scattering.
    Acerbo AS, Kwaczala AT, Yang L, Judex S, Miller LM.
    Calcif Tissue Int; 2014 Nov 15; 95(5):446-56. PubMed ID: 25190190
    [Abstract] [Full Text] [Related]

  • 16. The role of bisphosphonates in medical oncology and their association with jaw bone necrosis.
    Eid A, Atlas J.
    Oral Maxillofac Surg Clin North Am; 2014 May 15; 26(2):231-7. PubMed ID: 24794267
    [Abstract] [Full Text] [Related]

  • 17. Osteoblastic cell secretome: a novel role for progranulin during risedronate treatment.
    Romanello M, Piatkowska E, Antoniali G, Cesaratto L, Vascotto C, Iozzo RV, Delneri D, Brancia FL.
    Bone; 2014 Jan 15; 58():81-91. PubMed ID: 24120669
    [Abstract] [Full Text] [Related]

  • 18. Bisphosphonates for osteoporosis in primary biliary cirrhosis.
    Rudic JS, Giljaca V, Krstic MN, Bjelakovic G, Gluud C.
    Cochrane Database Syst Rev; 2011 Dec 07; (12):CD009144. PubMed ID: 22161446
    [Abstract] [Full Text] [Related]

  • 19. Regional bone metabolism at the lumbar spine and hip following discontinuation of alendronate and risedronate treatment in postmenopausal women.
    Frost ML, Siddique M, Blake GM, Moore AE, Marsden PK, Schleyer PJ, Eastell R, Fogelman I.
    Osteoporos Int; 2012 Aug 07; 23(8):2107-16. PubMed ID: 21983795
    [Abstract] [Full Text] [Related]

  • 20. Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study.
    Ringe JD, Farahmand P, Faber H, Dorst A.
    Rheumatol Int; 2009 Jan 07; 29(3):311-5. PubMed ID: 18762944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.